Leiomyoma Infarction after Uterine Artery Embolization: Influence of Embolic Agent and Leiomyoma Size and Location on Outcome

J Vasc Interv Radiol. 2017 Jul;28(7):1003-1010. doi: 10.1016/j.jvir.2017.03.015. Epub 2017 May 4.

Abstract

Purpose: To study the factors that might impact infarction of individual uterine leiomyomas and total tumor burden after uterine artery embolization (UAE).

Materials and methods: This retrospective study included 91 patients (mean age, 44 y [range, 34-54 y]) who underwent UAE with tris-acryl gelatin microspheres (TAGMs) or nonspherical polyvinyl alcohol (PVA) particles. Twenty-one patients were treated with PVA (23%) and 70 were treated with TAGMs (77%). A total of 356 uterine leiomyomas were assessed, with a median uterine volume of 533 cm3 (range, 321-848 cm3). A reader masked to demographic and technical details reviewed contrast-enhanced magnetic resonance images before and 3 months after UAE to estimate the extent of tumor infarction.

Results: There was no significant difference in global or individual tumor infarction rate between embolizations with TAGMs and PVA particles (P = .73 and P = .3, respectively). Global infarction was not affected by age (P = .53), race (P = .12), number of leiomyomas (P = .72), or uterine volume (P = .74). Leiomyoma size did not influence individual tumor infarction (P = .41). Leiomyoma location was the sole factor that influenced individual tumor infarction rates, with pedunculated serosal tumors significantly less likely to show complete infarction than transmural tumors (odds ratio, 0.24; P = .01).

Conclusions: Nonspherical PVA particles and TAGMs produce similar rates of uterine leiomyoma infarction. Complete infarction of individual tumors is less likely in serosal and pedunculated serosal tumors.

MeSH terms

  • Acrylic Resins
  • Adult
  • Female
  • Gelatin
  • Humans
  • Infarction / etiology*
  • Leiomyoma / therapy*
  • Middle Aged
  • Polyvinyl Alcohol
  • Retrospective Studies
  • Treatment Outcome
  • Uterine Artery Embolization*
  • Uterine Neoplasms / therapy*

Substances

  • Acrylic Resins
  • trisacryl gelatin microspheres
  • Gelatin
  • Polyvinyl Alcohol